Listed

Enveric Biosciences, Inc.

ENVBNasdaqCIK 890821HealthcareFiscal year ends Dec 31

Reports and events: 398 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Enveric Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2023-08-2107:55 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-029506
2023-08-1408:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-028048
2023-08-1117:11 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-027881
2023-07-2408:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-025323
2023-07-1708:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-024675
2023-06-0918:49 ET10-K/AAnnual report, amendedPeriod 2022-12-310001493152-23-020625
2023-06-0708:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-020350
2023-06-0616:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-020298
2023-06-0508:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-020079
2023-05-3008:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-019398
2023-05-2408:00 ET8-K1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors0001493152-23-018784
2023-05-2408:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018782
2023-05-2208:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018454
2023-05-1908:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018221
2023-05-1808:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-018039
2023-05-1509:25 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-016990
2023-04-1308:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-012081
2023-04-1010:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-011660
2023-04-0316:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-010655
2023-03-3117:25 ET10-KAnnual reportPeriod 2022-12-310001493152-23-010431
2023-03-2307:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-008635
2023-03-2107:49 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-008322
2023-03-1408:08 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-007535
2023-02-2816:18 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-23-006267
2023-02-2307:33 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-005819
2022-11-1416:37 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-032131
2022-10-2816:30 ET8-K5.07 Shareholder vote results0001493152-22-029856
2022-10-2408:58 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-029389
2022-10-0617:00 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-22-027827
2022-09-2317:02 ETDEF 14AProxy statementPeriod 2022-09-230001493152-22-026706
2022-09-2317:00 ET8-K4.01 Change of auditor0001493152-22-026704
2022-09-1409:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-025818
2022-09-1314:44 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-025724
2022-09-0115:57 ET8-K5.08 Item not in the standard list0001493152-22-024837
2022-08-1216:23 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-022369
2022-08-0216:30 ET8-K3.01 Delisting notice0001493152-22-021011
2022-07-2617:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-020362
2022-07-1908:25 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-019757
2022-07-1816:05 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-019579
2022-07-1417:09 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-019341
2022-07-1310:34 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-019134
2022-06-1509:00 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-016803
2022-05-3116:15 ETDEF 14AProxy statementPeriod 2022-05-310001493152-22-015464
2022-05-2416:48 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-014962
2022-05-1816:24 ET8-K/A3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-22-014325
2022-05-1316:16 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-013332
2022-05-1113:46 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-012822
2022-05-0417:27 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-012133
2022-05-0417:12 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-012127
2022-04-0113:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-22-008737

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.